JOURNAL OF PEDIATRICS, cilt.159, sa.3, ss.398-404, 2011 (SCI-Expanded)
Objective To evaluate the efficacy of inhaled salbutamol, a beta-2 adrenergic agonist, for the treatment of transient tachypnea of the newborn (TTN) and to determine whether inhaled salbutamol is safe in newborn infants.